There are two primary objectives to be addressed in this study: to assess the differential response in bioavailability and metabolic pathways between lean and obese individuals exposed to acute, short term (14 day), and long-term (10-week) consumption of polyphenol-rich fruits (berries and apple), and beverages (tea); and to determine the differential systemic and gut anti-inflammatory response between obese and lean individuals exposed to polyphenol-rich fruits (berries and apple), and beverages (tea).
Study Type
INTERVENTIONAL
Purpose
PREVENTION
Masking
NONE
Enrollment
28
Volunteers will be provided a controlled diet during the entirety of the 10 week treatment period. Meals will be prepared using traditional American foods. The controlled diet will include polyphenol-rich foods, including apples, berries, and green tea. A blend of multiple polyphenol-rich foods was chosen to investigate whole foods, multiple commodities, and multiple bioactives.
Beltsville Human Nutrition Center
Beltsville, Maryland, United States
Polyphenol metabolites - Wk 2
Polyphenol metabolites will be measured in blood and urine after 2 weeks of a controlled diet.
Time frame: 2 weeks after start of intervention
Polyphenol metabolites - Wk 4
Polyphenol metabolites will be measured in blood and urine after 4 weeks of a controlled diet. Weeks 3 and 4 will contain fruits and beverage rich in polyphenols.
Time frame: 4 weeks after start of intervention
Polyphenol metabolites - Wk 10
Polyphenol metabolites will be measured in blood and urine after 10 weeks of a controlled diet. Weeks 3 through 10 will contain fruits and beverage rich in polyphenols.
Time frame: 10 weeks after start of intervention
Systemic inflammation - Wk 2
Markers of inflammation (such as CRP, serum amyloid A, IL-6, IL-1B, TNF, and interferon-gamma will be measured.
Time frame: 2 weeks after start of intervention
Systemic Inflammation - Wk 4
Markers of inflammation (such as CRP, serum amyloid A, IL-6, IL-1B, TNF, and interferon-gamma will be measured.
Time frame: 4 weeks after start of intervention
Systemic Inflammation - Wk 10
Markers of inflammation (such as CRP, serum amyloid A, IL-6, IL-1B, TNF, and interferon-gamma will be measured.
Time frame: 10 weeks after start of intervention
Gastrointestinal Health - Wk 2
Gut permeability and inflammation will be measured in fecal samples.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Time frame: 2 weeks after start of intervention
Gastrointestinal Health - Wk 4
Gut permeability and inflammation will be measured in fecal samples.
Time frame: Wk 4
Gastrointestinal Health - Wk 10
Gut permeability and inflammation will be measured in fecal samples.
Time frame: 10 weeks after start of intervention